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Abstract
Background: Snakebite incidence in southwestern China is mainly attributed to one of the several venomous
snakes found in the country, the white-lipped green pit viper Trimeresurus albolabris. Since antivenom produced
from horses may cause numerous clinical side effects, the present study was conducted aiming to develop an
alternative antivenom antibody (immunoglobulin Y - IgY) from leghorn chickens.
Methods: IgY in egg yolk from white leghorn chicken previously injected with T. albolabris venom was extracted
by water, precipitated by ammonium sulfate and purified by affinity chromatographic system. IgY was identified by
SDS-PAGE, ELISA and Western blot, and its neutralizing assay was conducted on mice.
Results: Chickens injected multiple times with T. albolabris venom elicited strong antibody responses, and from
their egg yolk IgY was isolated and purified, which exhibited a single protein band on SDS-PAGE and two bands
(about 65 and 35 kDa, respectively) under reduced conditions. Immunoblot analysis revealed that these IgY are
polyclonal antibodies since they bind with most venom components. In the neutralizing assay, all mice survived
while the ratios of IgY/venom reached up to 3.79 (50.0 mg/13.2 mg).
Conclusions: IgY antibody response was successfully conducted in white leghorn chicken injected with T. albolabris
venom. IgY against T. albolabris venom was obtained for the first time, and it exhibited strong neutralizing potency
on mice. These results may lay a foundation for the development of IgY antivenom with clinical applications in the
future.
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Background
Snakebite, a neglected tropical disease, comprises an im-
portant worldwide public health concern, particularly in
the rural areas of tropical regions such as Africa, Asia
and Latin America [1, 2]. In southwestern China, the
frequent snakebite cases in rural regions are mainly at-
tributable to Trimeresurus albolabris, Naja naja and
Deinagkistrodon acutus. In these areas, antivenom raised
in horses are recommended for the treatment of most
snakebite cases. However, snake antivenom may provoke
numerous side effects such as anaphylactic shock, pyro-
gen reaction, serum sickness and skin rash [3]. In
addition, the preparation and purification of antivenom
from horse blood is laborious, time-consuming, expen-
sive and low yielding [4–7].
To overcome the disadvantages of antivenom made
from horse blood, it is essential to attempt other path-
ways to produce the antibodies against snake venom. In
this study, we employed chickens to produce antivenom
antibodies. Chicken egg yolk antibody (immunoglobulin
Y - IgY) has been identified as a potential, convenient,
non-invasive and inexpensive source of polyclonal anti-
bodies [8, 9]. The advantages of IgY are well documented
in the literature [10–12]. Currently, the preparations of
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IgY from chicken egg yolk have been successfully made
by immunizing chickens with venoms of several venom-
ous snake species [13–18]. For the first time, we used
venom of the white-lipped green pit viper (T. albolabris)
from southwestern China to immunize white leghorn
chickens and attempt to prepare and purify IgY, and fur-
ther to assess its neutralization efficacy.
Methods
Reagents
Freund’s complete adjuvant (FCA), incomplete Freund’s
adjuvant (IFA), Tween-20, ortho-phenylenediamine
(OPD) and 3,3’-diaminobenzidine tetrahydrochloride
(DAB) were purchased from Sigma (USA). Peroxidase
conjugated rabbit anti-chicken IgY was obtained from
Earthox (USA). All other reagents were of analytical
grade, purchased from local companies.
Animals
Seventeen-week-old white leghorn hens weighing 1.5 kg
each, purchased from a local poultry farm, in good
health and laying conditions (laying 5–6 eggs per week)
were used for the production of IgY against snake
venom. They were kept in individual cages with standard
food and water. Kunming mice (21–23 g each), obtained
from the Laboratory Animal Center of the Third Mili-
tary Medical University, were used to determine venom
lethality and its neutralization.
Venom
Venoms were milked from T. albolabris captured in
Guangxi province, China. Venom was lyophilized in a
ModulyoD-230 freeze dryer (Thermo Scientific, USA)
and stored at −20 °C until required.
Determination of LD50
Snake venom (0.5 mL in saline) was intraperitoneally
(IP) injected into Kunming mice. Mice were divided into
six groups of ten each and IP received the doses (1.82,
2.30, 2.87, 3.58, 4.48 and 5.60 mg/kg). The results were
recorded after 72 h and LD50 was calculated according
to the method described by Bliss [19] and expressed as
microgram (μg) per mouse.
Immunization assay
For the initial immunization, four hens were immunized
intramuscularly at multiple sites in their chest with
0.5 mL saline (containing 329 μg of snake venom) emul-
sified with an equal volume of FCA. On the 15th and
35th day after the first immunization, hens received
booster doses of 0.5 mL saline (containing 658 and
1316 μg of snake venom, respectively) emulsified with
an equal volume of IFA. Eggs were collected daily from
the first day to the 84th day after the first immunization,
individually identified, and stored at 4 °C until required.
Isolation and purification of IgY
The eggs obtained from the 21th to 84th day after the
first immunization were used to isolate IgY that was ob-
tained from yolk according to the modified method of
Akita et al. [20]. Briefly, the yolk, separated from the egg
white, was diluted ten-fold with cold distilled water and
adjusted a final pH of up to 5.2 with 0.1 N HCl under
stirring. The yolk suspensions were stored overnight at
4 °C. The supernatants containing the IgY, the water-
soluble fraction (WSF), were collected by centrifugation
at 10,000 × g for 30 min at 4 °C and were subjected to
35 % saturated ammonium sulfate solution for precipita-
tion. The salt pellet was collected by centrifugation at
10,000 × g for 30 min at 4 °C, the precipitated proteins
were dissolved in 0.02 M phosphate buffer (PBS, pH 7.5,
containing 0.6 M sodium sulfate) and dialyzed against
the same solution.
For further purification, isolated IgY was loaded on to
the HiTrap IgY Purification HP column (Amersham,
Sweden) equilibrated with 0.02 M PBS, pH 7.5, contain-
ing 0.6 M sodium sulfate and according to the Amer-
sham’s product instruction. Then, the fractions were
pooled, dialyzed against PBS and stored at −20 °C until
further use. The purity and titer of the preparations were
determined by SDS-PAGE and ELISA, respectively, and
their protein concentrations were determined by Lowry’s
method [21].
ELISA assay
The optimal dilution of antibodies was determined by
ELISA according to Voller et al. [22]. Briefly, polystyrene
96-well microtiter plates (Corning, USA) were coated
with 5 μg/mL snake venom in a coating buffer (0.1 M
carbonate bicarbonate, pH 9.6) for 12 h at 4 °C. The
wells were washed six times with washing buffer (PBS,
pH 7.4, containing 0.05 % Tween-20). The wells were
blocked for 2 h at 37 °C with a blocking buffer (3 % BSA
in washing buffer). The wells were washed again three
times with washing buffer. Serial dilutions of IgY sam-
ples in blocking buffer were prepared and 100 μL of
each diluted IgY sample was added into individual
coated wells and the plates were incubated at 37 °C for
1.5 h. The wells were washed five times with the same
washing buffer.
The plates were incubated with peroxidase conjugated
rabbit anti-chicken IgY (1:5000) for 45 min at 37 °C.
After the plates were washed five times, 100 μL of sub-
strate buffer (0.1 M citric acid, plus 0.2 M sodium di-
phosphate, 5.0 mL H2O, 5.0 mg OPD, 5 mL of H2O2)
were added and incubated at room temperature in the
dark for 20 min. The reaction was stopped by addition
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of 50 μL of 2 N sulfuric acid. Absorbance was read at
490 nm on an ELISA plate reader (Molecular Devices
Corporation, USA). IgY samples from the eggs collected
before immunization were used as negative control.
Wells free of venom were used as blanks.
Western blot assay
Western blot was carried out based on the modified pro-
cedure of Towbin et al. [23]. In brief, 12.5, 25 and 50 μg
of venom were mixed with SDS-PAGE sample buffer,
heated for 3 min at 100 °C under non-reducing condi-
tions, then separated on 10 % SDS-PAGE gel [24]. Pro-
teins on the gel were electroblotted for 2 h at 100 V
onto PVDF membranes in Mini Trans-Blot system (Bio-
Rad, USA). After blotting, the membranes were blocked
with blocking buffer (PBS, pH 7.4, with 0.5 % Tween-20
and 2 % non-fat dry milk) for 1 h at room temperature,
then washed with washing buffer (0.01 M PBS, pH 7.4,
0.05 % Tween-20). Blots were then incubated with di-
luted anti-venom IgY (1:1000) in the same blocking buf-
fer on a horizontal shaker at room temperature
overnight. After six washes, blots were incubated with
peroxidase conjugated rabbit anti-chicken IgY diluted
1:5000 in blocking buffer at room temperature for 2 h.
After three washes, blots were incubated in peroxidase
chromogenic substrate solution (0.01 M PBS, pH 7.4
with 0.05 % DAB and 0.03 % H2O2) for 20 s. Finally, the
immunoreactivity was stopped with distilled water.
Neutralization studies
To evaluate the neutralization effect of IgY, the challenge
dose of T. albolabris venom was four times larger than
the LD50 dose. Purified IgY at different concentrations was
mixed with the challenge dose of venom. The mixtures
were incubated at 37 °C for 30 min, and then 0.5 mL was
IP injected into four groups of ten mice for each dose.
The control group received the same amount of venom
dissolved in the same volume of saline solution with nega-
tive IgY. The survival was determined 72 h later.
Results
Antibody response
To evaluate IgY response in the immunization process,
the titer of IgY was carried out by ELISA. Following pri-
mary immunization, the chickens elicited comparable
antibody response, which was detected in serum by day
7. There was a sharp increase in antibody titer both in
serum and egg yolk, although the pre-booster response
was very low. This secondary response was maintained
thereafter by the second booster injection (Fig. 1).
Isolation and specific activity of IgY
After three steps (water dilution, ammonium sulfate pre-
cipitation and thiophilic chromatography), IgY from egg
yolk was obtained and exhibited a single protein band
(180 ~ 200 kDa) through SDS-PAGE. Under reduced
conditions, it presented two bands of about 65 kDa and
35 kDa, respectively (Fig. 2), which represented one
heavy chain and one light chain of IgY demonstrated by
Western blot analysis (Fig. 3). The average recovery of
venom-specific IgY from 127 eggs was about 18.43 %
(Table 1). The venom-specific activities of IgY in the dif-
ferent fractions, including water-soluble fraction (WSF),
salting-out fraction (SOF) and thiophilic-chromatography
Fig. 1 Primary and secondary antibody response in serum and egg yolk of chickens immunized with T. albolabris venom. Anti-T. albolabris (WSF, water-
soluble fraction) activity was determined by ELISA (as described in Materials and Methods section). Arrows indicate immunization
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fraction (TCF), were compared by ELISA, and the results
showed that the titer of TCF is twofold higher than SOF,
and 16 times higher when compared with to WSF. Obvi-
ously, the three purification steps used resulted in the en-
richment of venom-specific IgY.
Western blot
Different amounts of crude venom (50, 25 and 12.5 μg)
were subjected to SDS-PAGE, electroblotted onto a
PVDF membrane, and finally incubated with an enough
amount of IgY antivenom (1:1000). The results revealed
that IgY bound to venom protein components on PVDF
membrane in a dose-dependent manner (Fig. 4).
Lethality of venom and neutralization effect
The LD50 of T. albolabris venom is 3.3 mg/kg of mouse
body weight. All mice were dead within 2 h after injection
of 4 LD50 (13.2 mg/kg, defined as challenge dose). When
the different amounts of purified IgY (20.0 ~ 50.0 mg/kg)
were added to the venom challenge dose, the neutralizing
ability was evident in a dose-response manner, and when
IgY/venom ratios reached up to 3.79 (50.0 mg/13.2 mg)
all animals survived without noticeable toxic reactions.
Discussion
Usually, snake antivenom is produced by injecting horses
or sheep with small doses of the venom. The standard
Fig. 2 SDS-PAGE analysis (10 % resolving gel) of anti-T. albolabris IgY.
Lanes: (1) molecular weight marker; (2) non-reduced IgY; and (3)
reduced IgY
Fig. 3 Identification of anti-T. albolabris venom IgY. The reduced IgY
(50 μg) was separated on 10 % SDS-PAGE and stained with Coomassie
brilliant blue (lane M: molecular weight marker; lane 1: reduced IgY).
Result of Western blot test using peroxidase conjugated rabbit anti-chicken
IgY to detect the heavy chains (lane 2: A) and the light chains (lane 2: B)
Table 1 Recovery ratio of proteins and titer of IgY fractions






WSF 3.2 31.79 100
SOF 25.6 12.53 39.41
TCF 51.2 5.86 18.43
WSF water-soluble fraction, SOF salting-out fraction, TCF
thiophilic-chromatography fraction
Fig. 4 Anti-T. albolabris venom IgY combined with venom proteins by
Western blot analysis. Lane 1: 50 μg of venom on 10 % SDS-PAGE; lane
2: 50 μg of venom; lane 3: 25 μg of venom; and lane 4: 12.5 μg of
venom combined with a fixed amount of anti-T. albolabris venom
IgY (1:1000)
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procedure for immunization of horses for commercial
antivenom production requires at least ten injections
given in ten weeks for the first course, followed by two
more courses [25]. The use of chickens as substitutes of
horses or sheep for antibody production brings a num-
ber of advantages; the most evident is the non-invasive,
rapid and economical manner of producing antibodies
[26]. Compared to the production in horses or sheep,
the IgY technology presents several benefits: no bleed-
ing, only egg collection is required on immunization;
IgY isolation is fast and simple; and very low quantities
of antigen are required to obtain high and long-lasting
IgY titers in the yolk from immunized hens [27].
Initially, IgY antibodies were thought of as IgG-like
immunoglobulins [28]. However, there are important dif-
ferences between IgY and IgG regarding their function,
including: IgY does not bind the rheumatoid factor (RF)
whereas IgG molecules often cause false positive results
by interaction with RF in immunoassays; IgY do not inter-
fere with mammalian IgG and they do not activate the
mammalian complement system [29–31]. Previous studies
have shown that hens immunized with snake venoms pro-
duced IgY that could neutralize the toxic and lethal effects
of venoms and could serve to treat domestic animals
envenomed by snake [13–18]. The current study for the
first time describes the creation of anti-T. albolabris
venom antibody in chicken egg yolk and its efficacy in
neutralizing the lethal effects of T. albolabris venom.
In the current study, the antibody production in IgY egg
yolk started 15 days after the first injection of T. albolabris
venom, increasing progressively along the immunization
procedure, and attaining a plateau after the second
booster, which was maintained thereafter (Fig. 1). Anti-T.
albolabris venom antibody response in chicken proceeded
like the antibody response of other snake venoms reported
[17, 18, 25].
In the literature, it has been reported that high pure IgY
could be obtained through three principal steps [16–18,
25]. Isolation of total IgY in the egg yolk was carried out
under controlled conditions including low pH and low
ionic concentration of acidified water, so that the aggrega-
tion of yolk lipids and separation of IgY in the clear super-
natant occurred. The lipophilic solvents were used to
separate yolk lipids from soluble proteins, but the purity
and activity of the preparations by the lipophilic solvent
method was lower than by the water dilution method [32].
After precipitation of solid ammonium sulfate and thiophi-
lic chromatography, the TCF exhibited a single band (180
~ 200 kDa) under native state and two bands (about 68 and
25 kDa) under reduced condition on SDS-PAGE (Fig. 2),
which indicated the purity of obtained IgY. Additionally,
the reduced TCF was combined with polyclonal rabbit
anti-chick IgY by Western blot analysis (Fig. 3), which dem-
onstrated the TCF’s IgY activity. IgY activity in TCF was
found to be two and 16 times higher than its corresponding
activity in SOF and WSF, respectively. Obviously, as de-
scribed in previous studies, the three steps resulted in the
enrichment of venom-specific IgY [11, 20, 33]. The average
recovery of venom-specific IgY from 127 eggs was about
18.43 % and 5.86 g pure IgY was obtained (Table 1).
It has been confirmed by Western blot analysis that
the anti-T. albolabris IgY was able to recognize and bind
to most protein components of T. albolabris venom
(Fig. 4). This suggests that IgY is a specific anti-T. albo-
labris venom polyclonal antibody. A mixture of IgY and
venom was injected into mice and its neutralizing ability
was obvious in dose-dependent manner.
Conclusion
In conclusion, for the first time an IgY antivenom was
successfully raised through immunizing hens with T.
albolabris venom and had strong neutralizing ability
against the snake venom. The results may lay a founda-
tion for therapy of snakebites. However, further studies
are essential to confirm the safety and efficacy of such
finding as an antidote to human victims of snakebites.
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